Plus Therapeutics Stock Forecast

Sell candidate since May 28, 2026 Loss -33.75%

The Plus Therapeutics, Inc. stock price gained 7.58% on the last trading day (Thursday, 25th Jun 2026), rising from $3.96 to $4.26. During the last trading day the stock fluctuated 13.45% from a day low at $3.88 to a day high of $4.40. The price has fallen in 7 of the last 10 days and is down by -20.96% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 939 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $4.40 million.

The stock is moving within a very wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Plus Therapeutics, Inc. stock with a 90% probability to be traded between $2.76 and $7.41 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

PSTV Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, June 24, 2026, and so far it has risen 7.58%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Plus Therapeutics, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $5.50. On a fall, the stock will find some support from the short-term average at $4.19. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Plus Therapeutics, Inc. stock

Plus Therapeutics, Inc. finds support from accumulated volume at $4.07 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.522 between high and low, or 13.45%. For the last week, the stock has had daily average volatility of 7.85%.

Plus Therapeutics, Inc. is oversold on RSI14 (21). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (PSTV) For The Upcoming Trading Day Of Friday 26th

For the upcoming trading day on Friday, 26th we expect Plus Therapeutics, Inc. to open at $4.18, and during the day (based on 14 day Average True Range), to move between $4.04 and $4.48, which gives a possible trading interval of +/-$0.449 (+/-11.13%) up or down from last closing price. If Plus Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 11.13% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $4.07 (4.58%) than the resistance at $4.57 (7.28%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Plus Therapeutics, Inc. stock A Buy?

Plus Therapeutics, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -2.560 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 26, 2026 - $4.18 ( 1.89%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk